Cargando…
‘Long‐term cost‐effectiveness of Dexcom G6 real‐time continuous glucose monitoring system in people with type 1 diabetes in Australia: Comments on J. J. Isitt et al.’
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099386/ https://www.ncbi.nlm.nih.gov/pubmed/36271628 http://dx.doi.org/10.1111/dme.14988 |
| _version_ | 1785025040537878528 |
|---|---|
| author | Hellmund, Richard Welsh, Zoë |
| author_facet | Hellmund, Richard Welsh, Zoë |
| author_sort | Hellmund, Richard |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10099386 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100993862023-04-14 ‘Long‐term cost‐effectiveness of Dexcom G6 real‐time continuous glucose monitoring system in people with type 1 diabetes in Australia: Comments on J. J. Isitt et al.’ Hellmund, Richard Welsh, Zoë Diabet Med Letters John Wiley and Sons Inc. 2022-11-06 2023-02 /pmc/articles/PMC10099386/ /pubmed/36271628 http://dx.doi.org/10.1111/dme.14988 Text en © 2022 Abbott Laboratories. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters Hellmund, Richard Welsh, Zoë ‘Long‐term cost‐effectiveness of Dexcom G6 real‐time continuous glucose monitoring system in people with type 1 diabetes in Australia: Comments on J. J. Isitt et al.’ |
| title | ‘Long‐term cost‐effectiveness of Dexcom G6 real‐time continuous glucose monitoring system in people with type 1 diabetes in Australia: Comments on J. J. Isitt et al.’ |
| title_full | ‘Long‐term cost‐effectiveness of Dexcom G6 real‐time continuous glucose monitoring system in people with type 1 diabetes in Australia: Comments on J. J. Isitt et al.’ |
| title_fullStr | ‘Long‐term cost‐effectiveness of Dexcom G6 real‐time continuous glucose monitoring system in people with type 1 diabetes in Australia: Comments on J. J. Isitt et al.’ |
| title_full_unstemmed | ‘Long‐term cost‐effectiveness of Dexcom G6 real‐time continuous glucose monitoring system in people with type 1 diabetes in Australia: Comments on J. J. Isitt et al.’ |
| title_short | ‘Long‐term cost‐effectiveness of Dexcom G6 real‐time continuous glucose monitoring system in people with type 1 diabetes in Australia: Comments on J. J. Isitt et al.’ |
| title_sort | ‘long‐term cost‐effectiveness of dexcom g6 real‐time continuous glucose monitoring system in people with type 1 diabetes in australia: comments on j. j. isitt et al.’ |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099386/ https://www.ncbi.nlm.nih.gov/pubmed/36271628 http://dx.doi.org/10.1111/dme.14988 |
| work_keys_str_mv | AT hellmundrichard longtermcosteffectivenessofdexcomg6realtimecontinuousglucosemonitoringsysteminpeoplewithtype1diabetesinaustraliacommentsonjjisittetal AT welshzoe longtermcosteffectivenessofdexcomg6realtimecontinuousglucosemonitoringsysteminpeoplewithtype1diabetesinaustraliacommentsonjjisittetal |